Join 19,000+ global attendees and 1,700+ leading companies for four information-packed days to present new ideas, form bold ventures, and create global benefits in the world-changing industry of biotechnology.
Join 19,000+ global attendees and 1,700+ leading companies for four information-packed days to present new ideas, form bold ventures, and create global benefits in the world-changing industry of biotechnology.
Join 19,000+ global attendees and 1,700+ leading companies for four information-packed days to present new ideas, form bold ventures, and create global benefits in the world-changing industry of biotechnology.
A unique two-day intensive approach to find and to offer, in an international environment: AIC, Patents & Licensing, Co-Marketing of Bio-Nano-Pharma Technologies. Pharma Finance 2007 is not an arena-style conference. It is specifically designed to support in-depth partnership development and is therefore, by invitation only and limited to a select group of companies.
DAY 1 - May 10 - General presentations to the industrial and financial communities, features new products, technologies.
A unique two-day intensive approach to find and to offer, in an international environment: AIC, Patents & Licensing, Co-Marketing of Bio-Nano-Pharma Technologies. Pharma Finance 2007 is not an arena-style conference. It is specifically designed to support in-depth partnership development and is therefore, by invitation only and limited to a select group of companies.
DAY 1 - May 10 - General presentations to the industrial and financial communities, features new products, technologies.
REGISTRATION IS NOW OPEN
ACUMEN BIOFIN RODMAN & RENSHAW
4TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
MAY 1 4 -1 5 , 200 7
MONTE CARLO , MONACO
Conference Highlights:
Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference will be held on May 14-15 , 200 7 in Monte Carlo, Monaco. You will witness presentations by more than 2 00 emerging growth biotechnology companies at an event that rapidly has become the premier event on the Life Sciences calendar. Companies will share their accomplishments on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. The event will unite companies with institutional investors, venture capitalists, senior corporate executives and experts from the scientific and medical communities.
The Conference will include company presentations, breakout sessions, and one-on-one meetings with presenting companies.
REGISTRATION IS NOW OPEN
ACUMEN BIOFIN RODMAN & RENSHAW
4TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
MAY 1 4 -1 5 , 200 7
MONTE CARLO , MONACO
Conference Highlights:
Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference will be held on May 14-15 , 200 7 in Monte Carlo, Monaco. You will witness presentations by more than 2 00 emerging growth biotechnology companies at an event that rapidly has become the premier event on the Life Sciences calendar. Companies will share their accomplishments on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. The event will unite companies with institutional investors, venture capitalists, senior corporate executives and experts from the scientific and medical communities.
The Conference will include company presentations, breakout sessions, and one-on-one meetings with presenting companies.
The Biotechnology Industry Organization (BIO), in partnership with 11 state biotechnology associations and BIOTECanada will bring venture capitalists together with promising seed, early- and late-stage private biotechnology product and platform companies from the East Coast. The conference will showcase up to 100 individual company presentations to leading North American venture capital firms in the life sciences field. Workshops and plenary sessions will be offered on trends in the biotech industry, with special focus on key success factors for early-stage companies, R&D, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.
The Biotechnology Industry Organization (BIO), in partnership with 11 state biotechnology associations and BIOTECanada will bring venture capitalists together with promising seed, early- and late-stage private biotechnology product and platform companies from the East Coast. The conference will showcase up to 100 individual company presentations to leading North American venture capital firms in the life sciences field. Workshops and plenary sessions will be offered on trends in the biotech industry, with special focus on key success factors for early-stage companies, R&D, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.
Location: Loews Philadelphia Hotel, Philadelphia, PA
The signature event in Cambridge Healthtech Institute’s Biomarker Series, The Biomarker World Congress 2008 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers.
The Biotechnology Industry Organization (BIO), in partnership with 11 state biotechnology associations and BIOTECanada will bring venture capitalists together with promising seed, early- and late-stage private biotechnology product and platform companies from the East Coast. The conference will showcase up to 100 individual company presentations to leading North American venture capital firms in the life sciences field. Workshops and plenary sessions will be offered on trends in the biotech industry, with special focus on key success factors for early-stage companies, R&D, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.
Location: Loews Philadelphia Hotel, Philadelphia, PA
The signature event in Cambridge Healthtech Institute’s Biomarker Series, The Biomarker World Congress 2008 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers.
Location: Loews Philadelphia Hotel, Philadelphia, PA
The signature event in Cambridge Healthtech Institute’s Biomarker Series, The Biomarker World Congress 2008 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers.
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
Description:
The course approaches infectious disease from several perspectives and explores the underlying biology, epidemiology, clinical evaluation, diagnosis, treatment, and control of infections to infectious disease. The course will discuss the various types of infection including fungal, bacterial and viral and the role of laboratory testing in their diagnosis, treatment and control. The course will review urinary tract infections, gastric diseases, respiratory infections, skin, soft tissue and bone infections. Additionally the programme will also cover the issues surrounding community versus hospital acquired infection and include a session focussing specifically on sepsis and sceptic shock.
Detailed case studies will provide an understanding of strategies used in practice and discussion will be inherent throughout the course.
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
Description:
The course approaches infectious disease from several perspectives and explores the underlying biology, epidemiology, clinical evaluation, diagnosis, treatment, and control of infections to infectious disease. The course will discuss the various types of infection including fungal, bacterial and viral and the role of laboratory testing in their diagnosis, treatment and control. The course will review urinary tract infections, gastric diseases, respiratory infections, skin, soft tissue and bone infections. Additionally the programme will also cover the issues surrounding community versus hospital acquired infection and include a session focussing specifically on sepsis and sceptic shock.
Detailed case studies will provide an understanding of strategies used in practice and discussion will be inherent throughout the course.
Cleveland Biolabs, Inc. (CBLI) to present at the Robins Emerging Opportunities Investment Conference.
Cleveland Biolabs, Inc is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Research Radiobiology Institute.
To Register, contact Aimee Boutcher (973) 239-2878, or register online: Register Online
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
CANMEDBIO is an emerging technology showcase, seminar and partnering program for the CANadian MEDical device and BIOtechnology industries. Be a part of the event that will encourage increased commercialization of Canadian innovations and technology.
This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. We are pleased to have every region of the country participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success. Participants will take part in career fairs, tour our Canadian biotech companies, and see how biotechnology is vital to our future. Many more will hear from influential leaders of the industry and meet with federal and provincial decision makers.
Welcome to the Phacilitate Vaccine Forum Munich 2007
Phacilitate’s fifth annual European Vaccine Forum will once again provide an ideal opportunity for leaders from across the vaccines sector to meet, and to discuss solutions to their common strategic, regulatory and technological challenges. A stimulating blend of plenary presentations, workshops, breakout sessions and panel discussions will make for a highly interactive conference, complemented by superb networking over the course of the 3 days. Please visit the website for the latest information on the 2006 agenda and on the speaker panel.
PharmaJet has confirmed they will be exhibiting at the Munich Vaccine Forum 2007. The 10% early booking discount on booths and sponsorships runs out on 22nd December so contact David McCall now at david@phacilitate.co.uk (Tel: +44 (0)20 7839 6151) for more information on how your company can participate.
contact-person: David McCall
Email: david@phacilitate.co.uk
homepage: http://www.phacilitate.co.uk/pages/spring_vaccine/index.html
Welcome to the Phacilitate Vaccine Forum Munich 2007
Phacilitate’s fifth annual European Vaccine Forum will once again provide an ideal opportunity for leaders from across the vaccines sector to meet, and to discuss solutions to their common strategic, regulatory and technological challenges. A stimulating blend of plenary presentations, workshops, breakout sessions and panel discussions will make for a highly interactive conference, complemented by superb networking over the course of the 3 days. Please visit the website for the latest information on the 2006 agenda and on the speaker panel.
PharmaJet has confirmed they will be exhibiting at the Munich Vaccine Forum 2007. The 10% early booking discount on booths and sponsorships runs out on 22nd December so contact David McCall now at david@phacilitate.co.uk (Tel: +44 (0)20 7839 6151) for more information on how your company can participate.
contact-person: David McCall
Email: david@phacilitate.co.uk
homepage: http://www.phacilitate.co.uk/pages/spring_vaccine/index.html
Location: Hotel del Coronado, 1500 Orange Avenue, Coronado, California
The definitive annual update meeting for HIV healthcare providers, delivering expert reviews of the state-of-the-art in HIV treatment and care, HIV prevention, and the implications of basic science advances for patient management.
Welcome to the Phacilitate Vaccine Forum Munich 2007
Phacilitate’s fifth annual European Vaccine Forum will once again provide an ideal opportunity for leaders from across the vaccines sector to meet, and to discuss solutions to their common strategic, regulatory and technological challenges. A stimulating blend of plenary presentations, workshops, breakout sessions and panel discussions will make for a highly interactive conference, complemented by superb networking over the course of the 3 days. Please visit the website for the latest information on the 2006 agenda and on the speaker panel.
PharmaJet has confirmed they will be exhibiting at the Munich Vaccine Forum 2007. The 10% early booking discount on booths and sponsorships runs out on 22nd December so contact David McCall now at david@phacilitate.co.uk (Tel: +44 (0)20 7839 6151) for more information on how your company can participate.
contact-person: David McCall
Email: david@phacilitate.co.uk
homepage: http://www.phacilitate.co.uk/pages/spring_vaccine/index.html
Location: Hotel del Coronado, 1500 Orange Avenue, Coronado, California
The definitive annual update meeting for HIV healthcare providers, delivering expert reviews of the state-of-the-art in HIV treatment and care, HIV prevention, and the implications of basic science advances for patient management.
The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. The 2006 Meeting in Atlanta attracted more than 29,000 attendees from all over the world.
Location: Hotel del Coronado, 1500 Orange Avenue, Coronado, California
The definitive annual update meeting for HIV healthcare providers, delivering expert reviews of the state-of-the-art in HIV treatment and care, HIV prevention, and the implications of basic science advances for patient management.
The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. The 2006 Meeting in Atlanta attracted more than 29,000 attendees from all over the world.
Location: Hotel del Coronado, 1500 Orange Avenue, Coronado, California
The definitive annual update meeting for HIV healthcare providers, delivering expert reviews of the state-of-the-art in HIV treatment and care, HIV prevention, and the implications of basic science advances for patient management.
The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. The 2006 Meeting in Atlanta attracted more than 29,000 attendees from all over the world.
The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. The 2006 Meeting in Atlanta attracted more than 29,000 attendees from all over the world.
Bringing five cutting edge seminars comprising over 50 industry topics, covering advanced technologies to serve the needs of those involved in bioprocessing, pharmaceutical, and healthcare industries.
In this forum, you will hear new implementation and scale-up case studies that will help you move your systems forward, minimize investments, increase early stage capacity and speed time to clinic.
Additional Information
SWE Enterprises, Inc. invites you to attend the Strategies and Techniques for FORMULATION AND DEVELOPMENT of Protein Based Drugs conference for the Pharmaceutical and Biotech Industries. The conference will provide in-depth coverage on formulation, process development, stability and delivery of protein based biopharmaceuticals. It will be held at the La Jolla Marriott in San Diego, CA on June 4-5, 2007!
Register by May 4th and Receive a $300 DISCOUNT at http://www.sweinc.biz. Participate in an Industry Leading Eductional Conference at a First-Rate Venue.
Learn from the Experience of INDUSTRY EXPERTS from:
* WEST PHARMACEUTICAL SERVICES
* INTEGRITY BIOSCIENCE
* ALTHEA TECHNOLOGIES INC.
* BIOCONVERGANCE
* ACCELRYS
* AMBRX
* CRYOMETRIX INC.
Integrate China into your global strategy – from R&D to clinical trials. Hear first-time case studies, industry insights and exciting panel discussions on controversial topics to help you leverage China as your global partner in licensing, outsourcing or joint research and development.
Additional Information
The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. The 2006 Meeting in Atlanta attracted more than 29,000 attendees from all over the world.
Bringing five cutting edge seminars comprising over 50 industry topics, covering advanced technologies to serve the needs of those involved in bioprocessing, pharmaceutical, and healthcare industries.
In this forum, you will hear new implementation and scale-up case studies that will help you move your systems forward, minimize investments, increase early stage capacity and speed time to clinic.
Additional Information
SWE Enterprises, Inc. invites you to attend the Strategies and Techniques for FORMULATION AND DEVELOPMENT of Protein Based Drugs conference for the Pharmaceutical and Biotech Industries. The conference will provide in-depth coverage on formulation, process development, stability and delivery of protein based biopharmaceuticals. It will be held at the La Jolla Marriott in San Diego, CA on June 4-5, 2007!
Register by May 4th and Receive a $300 DISCOUNT at http://www.sweinc.biz. Participate in an Industry Leading Eductional Conference at a First-Rate Venue.
Learn from the Experience of INDUSTRY EXPERTS from:
* WEST PHARMACEUTICAL SERVICES
* INTEGRITY BIOSCIENCE
* ALTHEA TECHNOLOGIES INC.
* BIOCONVERGANCE
* ACCELRYS
* AMBRX
* CRYOMETRIX INC.
Integrate China into your global strategy – from R&D to clinical trials. Hear first-time case studies, industry insights and exciting panel discussions on controversial topics to help you leverage China as your global partner in licensing, outsourcing or joint research and development.
Additional Information
Bringing five cutting edge seminars comprising over 50 industry topics, covering advanced technologies to serve the needs of those involved in bioprocessing, pharmaceutical, and healthcare industries.
In this forum, you will hear new implementation and scale-up case studies that will help you move your systems forward, minimize investments, increase early stage capacity and speed time to clinic.
Additional Information
Integrate China into your global strategy – from R&D to clinical trials. Hear first-time case studies, industry insights and exciting panel discussions on controversial topics to help you leverage China as your global partner in licensing, outsourcing or joint research and development.
Additional Information
With staggering growth rates, the booming Biopharmaceutical industry has been increasingly diverting resources to protein research.
Great contributions have been made through academic research but it is the pharmaceutical industry that solely faces unique challenges, in its strive to progress compounds into novel drugs:
- Targeting Expression and purification demands
- Optimizing Efficacy and activity levels
- Overcoming challenges in structural research for drug design
The SMi Group's 3rd Annual Global Protein Summit is designed to meet the needs of the industry. Bringing together Vice Presidents, Directors, Heads and leading Researchers from the pharmaceutical industry to share successes and discuss the critical issues surrounding the development of innovative protein drug compounds.
